ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,223.08
0.01%
Dow Jones
39,457.92
-0.14%
US Dollar vs MXN
16.80595
0.14%
Brent Oil
83.205
1.00%
Bitcoin
63,008.50
2.54%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Dyne Therapeutics Inc (DYN)

  7. Dyne Therapeutics Inc (DYN) Noticias

DYN Dyne Therapeutics Inc

26.405
0.405 (1.56%)
Última actualización: 14:01:47
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Dyne Therapeutics Inc DYN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.405 1.56% 26.405 14:01:47
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
26.31 26.215 28.00 26.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
27/3/202415:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
27/3/202407:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
25/3/202406:30GLOBEDyne Therapeutics Announces CEO Transition
13/3/202406:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
11/3/202416:36EDGAR2Form 144 - Report of proposed sale of securities
11/3/202416:35EDGAR2Form 144 - Report of proposed sale of securities
11/3/202416:35EDGAR2Form 144 - Report of proposed sale of securities
08/3/202415:53EDGAR2Form 144 - Report of proposed sale of securities
07/3/202419:19EDGAR2Form 144 - Report of proposed sale of securities
07/3/202419:18EDGAR2Form 144 - Report of proposed sale of securities
07/3/202419:16EDGAR2Form 144 - Report of proposed sale of securities
05/3/202407:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
05/3/202406:41EDGAR2Form 8-K - Current report
05/3/202406:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202406:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202406:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
01/3/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:33EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:08EDGAR2Form 144 - Report of proposed sale of securities
29/2/202418:49EDGAR2Form 144 - Report of proposed sale of securities
23/2/202416:23EDGAR2Form 144 - Report of proposed sale of securities
14/2/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:15GLOBEDyne Therapeutics Announces Upcoming Presentations on..
14/2/202407:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202416:40EDGAR2Form 144 - Report of proposed sale of securities
01/2/202406:30GLOBEDyne Therapeutics to Present at February Investor..
26/1/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202418:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202418:46EDGAR2Form 144 - Report of proposed sale of securities
11/1/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202415:05GLOBEDyne Therapeutics Announces Closing of Public Offering of..
05/1/202415:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202407:02EDGAR2Form 8-K - Current report
05/1/202406:30GLOBEDyne Therapeutics to Present at 42nd Annual J.P. Morgan..
04/1/202421:46GLOBEDyne Therapeutics Announces Pricing of $300 Million Public..
04/1/202420:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202420:45EDGAR2Form 144 - Report of proposed sale of securities
04/1/202420:45EDGAR2Form 144 - Report of proposed sale of securities
04/1/202420:19EDGAR2Form S-3MEF - Registration adding securities to prior Form..
04/1/202416:12EDGAR2Form 8-K - Current report
03/1/202419:14EDGAR2Form 144 - Report of proposed sale of securities
03/1/202419:12EDGAR2Form 144 - Report of proposed sale of securities
03/1/202415:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202415:25GLOBEDyne Therapeutics Announces Proposed Public Offering of..
03/1/202405:37EDGAR2Form 8-K - Current report
03/1/202405:30GLOBEDyne Therapeutics Announces Positive Initial Clinical Data..
02/1/202415:05GLOBEDyne Therapeutics to Host Virtual Event Tomorrow, January 3..
29/12/202320:03EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
DYN
Dyne Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados